| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/12/2009 | EP1616181B1 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 08/12/2009 | EP1550672B1 Chimeric antagonist anth1 |
| 08/12/2009 | EP1525478B1 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3-expressing tumors |
| 08/12/2009 | EP1504104B1 Insect resistant plants and methods for making the same |
| 08/12/2009 | EP1465912B9 Chimeric tnf ligands |
| 08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
| 08/12/2009 | EP1416048B1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 08/12/2009 | EP1401376A4 Colloidal metal compositions and methods |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1344066B1 Protein s functional assay |
| 08/12/2009 | EP1299414B1 Fluorescent proteins |
| 08/12/2009 | EP1259608B1 Modified fluorescent proteins |
| 08/12/2009 | EP1198589B9 Tenascin-c nucleic acid ligands |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP1137941B1 Protein scaffolds for antibody mimics and other binding proteins |
| 08/12/2009 | EP1127944B9 Methods for screening compounds inhibiting inflammatory cytokine production |
| 08/12/2009 | EP0898580B9 Methods and means for inhibition of cdk4 activity |
| 08/12/2009 | EP0771322B9 Abundant extracellular products and methods for their production and use |
| 08/12/2009 | CN101506369A Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV in insect cells |
| 08/12/2009 | CN101506365A Biosilica-adhesive protein nanocomposite materials: synthesis and application in dentistry |
| 08/12/2009 | CN101506359A Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
| 08/12/2009 | CN101506235A Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 08/12/2009 | CN101506234A Identification and use of GPRC variants in the treatment and diagnosis of Parkinson's disease |
| 08/12/2009 | CN101506233A Transglutaminase variants with improved specificity |
| 08/12/2009 | CN101506232A Recombinant interferon-beta with enhanced biological activity |
| 08/12/2009 | CN101506231A Method of screening for compounds with anti-amyloid properties |
| 08/12/2009 | CN101506230A Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| 08/12/2009 | CN101506229A A novel gene from hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same |
| 08/12/2009 | CN101506228A Cysteine-tagged staphylococcal protein G variant |
| 08/12/2009 | CN101506227A OB-fold domains |
| 08/12/2009 | CN101506226A Improved variants of pigment epithelium derived factor and uses thereof |
| 08/12/2009 | CN101505786A A novel peptide involved in energy homeostasis |
| 08/12/2009 | CN101505780A Treatment of development-related disorders |
| 08/12/2009 | CN101503726A Factor VII or VIIa-like molecules |
| 08/12/2009 | CN101503725A Technique for improving purity of diphtheria toxoid |
| 08/12/2009 | CN101503693A Halimodendron halodendron ERF transcription factor cDNA sequence, expression vector and use thereof |
| 08/12/2009 | CN101503690A Method for promoting plant seed augmentation and cotton fibre growth by using RDL1 gene |
| 08/12/2009 | CN101503687A Procambarus clarki astacidin antibacterial peptide gene, coded antibacterial peptide thereof and use |
| 08/12/2009 | CN101503470A RhDSL recombinant protein and preparation thereof |
| 08/12/2009 | CN101503469A Method for extracting soy protein, oligosaccharide and isoflavone from soybean whey by two-stage two-segment film |
| 08/12/2009 | CN101503468A Protein related to pollen germination and/or pollen tube growth, coding gene and use thereof |
| 08/12/2009 | CN101503467A Plant stress tolerance related transcription factor GmNAC20, coding gene and use thereof |
| 08/12/2009 | CN101503466A Birdsfoot trefoil root flower type and inflorescence structure regulating gene, coding protein and use thereof |
| 08/12/2009 | CN101503465A Method for separating and extracting dinoflagellate cell wall protein |
| 08/12/2009 | CN101503464A Novel Bt protein Cry30Fa1, coding gene thereof and use |
| 08/12/2009 | CN101503463A Novel Bt protein Cry53Ab1, coding gene thereof and use |
| 08/12/2009 | CN101503462A Method for removing endotoxin in influenza virus stock solution |
| 08/12/2009 | CN101503461A Polypeptide with liver cancer apoptosis reducing function |
| 08/12/2009 | CN101503460A IgE antigenicity sequence and preparation of branched multiple antigenic peptides |
| 08/12/2009 | CN101503457A Column chromatography PEG and interferon analogue protein N-terminal site-directed coupling method and product thereof |
| 08/12/2009 | CN100526884C Binding of pathological forms of prion proteins |
| 08/12/2009 | CN100526465C Raising plant cold endurance and salt tolerance by means of transcription factor gene SNAC2 of rice |
| 08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
| 08/12/2009 | CN100526455C Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability |
| 08/12/2009 | CN100526332C Application of endothelium inhibitant for preducing medicament for retina disease therapy |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/11/2009 | US7572963 Maize variety PHNWJ |
| 08/11/2009 | US7572951 Isolated nucleic acid sequence encoding a viral movement protein is used for genetic engineering a plant which is resist to virus, viral disease; transgenic plants, seeds; exogenous gene expression; agriculture crops |
| 08/11/2009 | US7572949 SKN-1 and GSK-3 genes and proteins |
| 08/11/2009 | US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572894 Preparing a fibrous protein smectic hydrogel by way of a solvent templating process |
| 08/11/2009 | US7572893 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state |
| 08/11/2009 | US7572892 Cytokine zalpha11 ligand fusion proteins |
| 08/11/2009 | US7572891 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 08/11/2009 | US7572890 Having activities to inhibit Hemagglutination by Influenza Viruses; lacks dihydrofolate reductase, possesses resistance to both neomycin and methotrexate |
| 08/11/2009 | US7572889 Bt toxin receptors from lepidopteran insects |
| 08/11/2009 | US7572888 Fusion protein comprising arrestin and green fluorescent protein for use in identifying ligands for g-protein coupled receptors |
| 08/11/2009 | US7572887 Gene expressed in prostate cancer, methods and use thereof |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572885 Isolated GAGE-7B and 8 proteins |
| 08/11/2009 | US7572884 Method for making acylated polypeptides |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/11/2009 | US7572772 Use preventing transplant rejection, treating autoimmune diseases, and in leukocyte typing and FAC sorting; CD28/CTLA4Ig fusion proteins |
| 08/11/2009 | US7572770 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 08/11/2009 | US7572769 Fibrin adhesive granulate and method for its preparation |
| 08/11/2009 | US7572765 polypeptides or fragments used for treating bone disorders such as osteoporosis |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572633 Use of the adenoviral E2 late promoter |
| 08/11/2009 | US7572629 A gene construct incorporating any two luciferase genes which emit lights with different colors using an identical substrate such that the gene can be stably expressed in mammalian cells; optimize a reporter gene capable of determining or quantifying multiple transcription activities simultaneosly |
| 08/11/2009 | US7572628 Eukaryotic layered vector initiation systems |
| 08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
| 08/11/2009 | US7572617 Thermostable ribonuclease H obtained from Archeoglobus profundus |
| 08/11/2009 | US7572599 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 08/11/2009 | US7572598 Preparation comprising albumin esterified with a labeled substance for diagnosis of pancreatic exocrine function |
| 08/11/2009 | US7572594 Screening assays for agonists or antagonists or receptor activator of NF-κB |
| 08/11/2009 | US7572589 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 08/11/2009 | US7572587 CryET29 (delta-endotoxin with activity against fleas and beetles); insecticidal activity against not only insects of the order Coleoptera, but also against fleas, and in particular larvae of the cat flea, Ctenocephalides felis |
| 08/11/2009 | US7572580 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 08/11/2009 | US7572576 Analyzing two or more polymorphisms selected from among 4 gene polymorphisms having been revealed as relating to hypertension determining the genotype of a nucleic acid sample based on the polymorphism data obtained in first step, predicting the genetic risk ; high accuracy |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572465 Isolated material having an anti-organotrophic effect |
| 08/11/2009 | US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 08/11/2009 | US7572454 From Canine Distemper Virus; vaccines; luteinizing hormone releasing hormone |
| 08/11/2009 | US7572453 Envelope glycoproteins; capsids; immunogens |
| 08/11/2009 | US7572452 Utilizing polypeptide (p43) of amino acid sequence 1; inducting macrophage monocyte and endothelial cell reepithelization, proliferation of fibroblasts and/or angiogenesis; topical skin treatment |
| 08/11/2009 | US7572447 Methods and compositions for selective modulation of vascularization |